SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 13776.60 millions during the quarter ended March 2022. The figure stood at Rs. 13987.40 millions during the year-ago period.Net profit declined -24.44% to Rs. 2212.20 millions from Rs. 2927.80 millions.The Operating Profit of the company witnessed a decrease to 3752.00 millions from 4681.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 13776.60 13987.40 -1.51 47070.40 47687.20 -1.29 47070.40 47687.20 -1.29
Other Income 22.90 57.20 -59.97 215.50 273.20 -21.12 215.50 273.20 -21.12
PBIDT 3752.00 4681.70 -19.86 13067.50 15371.90 -14.99 13067.50 15371.90 -14.99
Interest 292.90 210.60 39.08 958.60 659.20 45.42 958.60 659.20 45.42
PBDT 3459.10 4471.10 -22.63 12108.90 14712.70 -17.70 12108.90 14712.70 -17.70
Depreciation 609.40 507.30 20.13 2354.80 1966.40 19.75 2354.80 1966.40 19.75
PBT 2849.70 3963.80 -28.11 9754.10 12746.30 -23.48 9754.10 12746.30 -23.48
TAX 637.50 1036.00 -38.47 2253.20 3185.20 -29.26 2253.20 3185.20 -29.26
Deferred Tax -127.00 -77.40 64.08 -61.00 -164.60 -62.94 -61.00 -164.60 -62.94
PAT 2212.20 2927.80 -24.44 7500.90 9561.10 -21.55 7500.90 9561.10 -21.55
Equity 1074.70 1073.20 0.14 1074.70 1073.20 0.14 1074.70 1073.20 0.14
PBIDTM(%) 27.23 33.47 -18.63 27.76 32.23 -13.88 27.76 32.23 -13.88

Laurus Labs Share Price

1164.00 -2.50 (-0.21%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×